Takeda Pharmaceutical intends to sell its Osaka, Japan, headquarters ahead of the planned purchase of Shire for $62 billion. The sale of the headquarters property could net Takeda more than $540 million.
Takeda to sell Osaka headquarters ahead of Shire purchase
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.